22OCT

Humanoid's buyers wrote the $152m cheque

4 min read

16:30UTC

Humanoid raised $152m at a $1.35bn valuation on 21 July. Schaeffler and Bosch signed as investors, customer and factory at the same time.

← Back to Stryker agrees option to buy CMR Surgical Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Humanoid's valuation rests on a signed customer and a contracted factory, not on a demonstration.

Humanoid, a two-year-old London robotics company, raised $152 million on Tuesday 21 July at a $1.35 billion valuation⁠¹. Prime Movers Lab led the Series A, with Schaeffler, Bosch, Fubon Financial and Aglae Ventures alongside it. One of those new investors had already contracted to deploy the robots it was buying into.

Schaeffler and Bosch each hold three positions at once. Schaeffler holds equity and has signed what Humanoid calls the industry's largest publicly announced commercial agreement, covering deployment of thousands of the wheeled HMND 01 platform in manufacturing environments⁠². Bosch holds equity and is the contract manufacturer, supplying production capability alongside strategic and technical consulting. Investor, customer and factory, carried by the same two signatures.

Forbes puts Bosch's potential output at 100,000 units over five years, which is forward-looking rather than a booked reservation, and Humanoid's own announcement gives no unit figure for either partner⁠³⁠⁴. Read the mechanism, not the ceiling.

That combination is why a company founded in 2024 prices above $1 billion on a Series A, the first priced institutional round. A demo reel supports a valuation until somebody asks who is buying and who is building. Humanoid can name both.

The HMND 01 rolls on wheels rather than legs, and the choice is regulatory as much as engineering. A wheeled machine clears European safety certification faster than a bipedal one, so Humanoid trades capability for a shorter route to a factory floor. The robots run a proprietary control system the company calls KinetIQ, and the first beta units reach customers from the fourth quarter of 2026⁠⁵.

Bosch and Schaeffler have taken this position before, and recently. Both back Neura Robotics, the German Humanoid company that reached roughly $7 billion in June, a month before Humanoid's round⁠⁶. Two industrial groups holding the same triple position across two Humanoid companies looks like a sector strategy rather than a quirk of one cap table.

British hardware has reached this scale on investor money before. Oxford Quantum Circuits raised £260 million in June, though the British Business Bank co-invested rather than leading it. Only one precedent in our record has the same shape: SAP took a strategic stake in Conduct's $60 million round in June and embedded the product inside its own software, hedging its own customer base rather than backing a market.

UKTN reported the round at £114m the following day. The two figures reconcile as the same money converted, and we use the fuller account's dollar terms and its 21 July date⁠⁷⁠⁸.

Deep Analysis

In plain English

Humanoid is a British company building HMND 01, a robot on wheels rather than legs, meant to do physical tasks in factories. It raised $152m from investors including a fund called Prime Movers Lab. Two large German companies, Bosch and Schaeffler, are involved in three different ways at once: they put money in as investors, Schaeffler has agreed to buy and use robots on its own factory floors, and Bosch will be the factory that actually builds the robots for Humanoid. That three-way arrangement, customer and investor and manufacturer combined, is unusual and is why this round drew attention beyond its size.

Deep Analysis

Root Causes

Bosch and Schaeffler both sell components into a combustion-engine supply chain that is shrinking as European carmakers cut output; contract-manufacturing a robot for a new customer fills capacity that a shrinking automotive order book has freed up, without either company having to build a dedicated robotics factory from scratch.

Humanoid needed a manufacturing partner because building a wheeled platform like HMND 01 at the volumes Schaeffler's factories would require exceeds what a five-year-old startup can finance or engineer alone; Bosch's existing precision-manufacturing lines, built for automotive tolerances, transfer directly to actuator and joint production without new tooling.

What could happen next?

Precedent
An industrial buyer acting as investor, customer and manufacturer in one deal may become the template UK hardware startups pitch to European conglomerates next, rather than pitching pure financial VCs.
Risk
If Schaeffler's deployment underperforms on its own factory floor, the reputational damage falls on both the customer and the contract manufacturer, who are also equity holders with no arm's-length distance from the outcome.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: Toyota took an equity stake in eVTOL maker Joby Aviation in 2020 and committed its own production-system engineers to help Joby scale manufacturing, the same investor-plus-manufacturing-partner structure Bosch and Schaeffler now run for Humanoid; Joby's aircraft still had no FAA type certificate five years later.

Counter-parallel: Foxconn agreed in 2020 to build Fisker's electric cars as contract manufacturer, a capacity reservation almost identical in form to Bosch's role here; Fisker filed for bankruptcy in 2024 having delivered a fraction of the volumes the manufacturing deal implied.

Bosch has agreed to hold capacity available and consult on production engineering, a reservation rather than a purchase order; no invoice exists until Schaeffler actually places an order and Humanoid actually delivers units, so the deal carries none of the revenue Humanoid can book today. Forbes' figure of 100,000 units over five years is Bosch's own forward planning assumption, not a number written into any contract Humanoid has disclosed.

Set against Kraken Technology Group's $175m raise the same month, which also crossed a valuation threshold on a single-source report with no named lead investor, Humanoid's round is unusual for having two named industrial counterparties rather than one, but neither the unit count nor the contract terms are independently verifiable from the public announcement.

Consensus view: The International Federation of Robotics, whose 2022-24 president Marina Bill ran ABB's robotics division, tracks Humanoid deployment through paid pilot contracts rather than press releases; on that measure Schaeffler's agreement to take HMND 01 units into its own bearing plants counts as the first European Humanoid deal with a named industrial deployment site rather than a lab demonstration.

Counter-view: Wang Weiming, who speaks for China's Ministry of Industry and Information Technology on equipment policy, has set a 2027 target for Chinese Humanoid firms to reach mass production first, arguing that state-directed component supply chains for actuators and reducers will out-scale Western deals built one bilateral contract at a time.

Key tension: Whether a single anchor customer's factory floor, however large, can teach a Humanoid enough varied tasks to generalise, or whether only China's breadth of parallel deployments across many factories gets there first.

First Reported In

Update #13 · Humanoid hit $1.35bn on a customer order

Forbes· 31 Jul 2026

Read original →

Causes and effects

Caused by

OQC raises £260m in Europe's biggest quantum round

OQC's £260m raise set the last British hardware valuation precedent Humanoid's round now exceeds.

Occurred 2 Jun 2026

Read story →

Conduct takes $60m as SAP buys in

Conduct's SAP-backed round is the closest prior precedent for an industrial investor embedding inside a UK cap table.

Occurred 17 Jun 2026

Read story →

This Event

Humanoid's buyers wrote the $152m cheque

Two German industrial groups took equity, contracted for deployment and reserved manufacturing capacity in one transaction, which is how a two-year-old London company priced above a billion dollars on its first institutional round.

Led to

Nscale files for New York at $14.6bn

Nscale is the third British AI company priced on contracted commitments, after Humanoid's industrial orders.

Occurred 18 Sept 2026

Read story →

Different Perspectives

Abu Dhabi Investment Council

The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

CDP Venture Capital

CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.

EDBI

Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.

Forbion

Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.

British Business Bank

The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.

Stryker Corporation

Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.